Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Centogene N.V. (NQ: CNTG )

0.7800 -0.0400 (-4.88%)
Streaming Delayed Price Updated: 3:59 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,276
Open 0.8400
Bid (Size) 0.7800 (72)
Ask (Size) 0.8000 (1)
Prev. Close 0.8200
Today's Range 0.7633 - 0.8400
52wk Range 0.6100 - 4.380
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
CENTOGENE Appoints Ian Rentsch as Chief Commercial Officer and General Manager - Pharma
From Centogene NV
Via Globe NewsWire
CENTOGENE to Participate in Upcoming Conferences in March
From Centogene NV
Via Globe NewsWire

Performance

YTD
-12.36%
-12.36%
1 Month
-30.36%
-30.36%
3 Month
-7.13%
-7.13%
6 Month
-41.74%
-41.74%
1 Year
-80.98%
-80.98%

More News

Read More
In the Lead-Up to Rare Disease Day, CENTOGENE Expands Observational Study to Advance the Genetic Understanding of Frontotemporal Dementia (FTD)
From Centogene NV
Via Globe NewsWire
Analyst: Centogene Leveraging The Largest BioDatabank For Rare Diseases
Via Benzinga
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
From Centogene NV
Via Globe NewsWire
CENTOGENE to Participate in Upcoming Conferences in February in the Lead Up to Rare Disease Day
From Centogene NV
Via Globe NewsWire
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics
From Twist Bioscience Corporation
Via Business Wire
CENTOGENE and Denali Therapeutics Extend World’s Largest Observational Study on Parkinson’s Disease Genetics
From Centogene NV
Via Globe NewsWire
CENTOGENE Announces Its Attendance at the 41st Annual J.P. Morgan Healthcare Meeting and Fierce JPM Week in San Francisco
From Centogene NV
Via Globe NewsWire
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
From Centogene NV
Via Globe NewsWire
CENTOGENE Receives Nasdaq Non-Compliance Notice
From Centogene NV
Via Globe NewsWire
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
Via Benzinga
CENTOGENE to Participate in Upcoming Conferences in December
From Centogene NV
Via Globe NewsWire
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
CENTOGENE Announces Changes to Supervisory Board, Including Appointment of Mary Sheahan
From Centogene NV
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
CENTOGENE to Participate in Upcoming Conferences in November
From Centogene NV
Via Globe NewsWire
CENTOGENE Launches Rare and Neurodegenerative Disease Biodata Network
From Centogene NV
Via Globe NewsWire
CENTOGENE to Participate in Upcoming Partnering Conferences in October
From Centogene NV
Via Globe NewsWire
CENTOGENE Reaches 12,500 Patient Milestone in World’s Largest Observational Study on Parkinson’s Disease Genetics
From Centogene NV
Via Globe NewsWire
Dammam Valley and Arcensus GmbH to establish Saudi-German Genomic Center in Riyadh
Via ACN Newswire
Dammam Valley/KSA to acquire the majority of Arcensus GmbH/Germany to accelerate the global implementation of Whole Genome Sequencing in genetic diagnostics and delivery of breakthrough technologies in genomic bioinformatics
Via ACN Newswire
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.